Techniques for targeting screening in ulcerative colitis.
Patients with longstanding chronic ulcerative colitis are "at risk" of developing colorectal cancer. Approximately 1 in 6 patients will die as a result of colorectal malignancy, which can often be difficult to detect using conventional "white light" colonoscopy. New endoscopic techniques and technologies including the use of dye sprays, "chromoendoscopy", high magnification chromoscopic colonoscopy and recently chromoscopic assisted confocal laser scanning in vivo endomicroscopy have now been introduced to improve the diagnostic yield of intraepithelial neoplasia at screening colonoscopy. This review details the true "risk" of colorectal cancer complicating ulcerative colitis, discusses the objective evidence to support current endoscopic screening guidelines, and describes the imminent technological paradigm shift about to occur in the endoscopic management and detection of intraepithelial neoplasia.
Hurlstone
David Paul
DP
Department of Endoscopy, Royal Hallamshire Hospital, Sheffield, UK. p.hurlstone@shef.ac.uk
Brown
Steve
S
D014408:Biomarkers, Tumor / Q000378:metabolism; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D003113:Colonoscopy / Q000379:methods; D015179:Colorectal Neoplasms / Q000150:complications* / Q000175:diagnosis; D032921:Consensus; D019317:Evidence-Based Medicine; D005544:Forecasting; D006801:Humans; D008403:Mass Screening / Q000379:methods*
D014408:Biomarkers, Tumor